Abstract
Sacral nerve modulation represents a well-established functional therapy for urinary retention. It may restore voiding either in urinary retention sustained by detrusor underactivity (or acontractility) or by urethral dysfunction (dysfunctional voiding).
With more than twenty years of clinical application, SNM treatment represents the best functional therapeutic option to reserve for urinary retention patients. Optimization of patient selection is mandatory to obtain the best result from SNM therapy. In case of urinary retention sustained by detrusor acontractility, detrusor contractility test (DCT) represents a tool to rule out myogenic detrusor damage, to be excluded from SNM procedure. In the last decades research in SNM led to a more reliable test selection procedure with optimization of clinical results. SNM therapy in urinary retention needs dedicate specialists to accurately select and follow up the patients and adequate nursing by dedicated and trained staff.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerebroeck P, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49
Schmidt RA, Senn E, Tanagho EA (1990) Functional evaluation of sacral nerve root integrity. Report of a technique. Urology 35(5):388–392
Schmidt RA (1988) Applications of neurostimulation. Neurourol Urodyn 7:585
Tanagho EA, Schmidt RA (1988) Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 140:1331–1339
Siegel SW (1992) Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin North Am 19(1):163–170
Jonas U, Fowler CJ, Grünewald V, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, Hassouna MM, Hombergh U, Janknegt R, van Kerrebroeck PE, Lylcklama a Nijeholt AA, Siegel SW, Schmidt RA (2001) Efficacy of sacral nerve stimulation for urinary retention; results up to 18 months after implantation. J Urol 165:15–19
Madersbacher H, Cardozo L, Chapple C, Abrams P, Toozs-Hosbon P, Young JS, Wyndaele JJ, De Watcher S, Campeau L, Gajewsky JB (2012) What are the causes and consequences of bladder overdistension?: ICI-RS 2011. Neurourol Urodyn 31:317–321
De Souza GM, Costa WS, Bruschini H (2004) Morphological analysis of the acute effects of overdistension on the extracellular matrix of the rat urinary bladder wall. Ann Anat 186:55–59
Fowler CJ (1988) Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ 297:1436–1438
Dasgupta R, Critchley HD, Dolan RJ, Fowler CJ (2005) Changes in brain activity following sacral neuromodulation for urinary retention. J Urol 174:2268–2272
Goodman LS, Gilman A (1996) The pharmacological basis of therapeutics, 9th edn. Mc Graw Hill, New York
Bertapelle P, Bodo G, Carone R (2008) Detrusor acontractility in urinary retention: detrusor contractility test as exclusion criteria for sacral neurostimulation. J Urol 180:215–216
Thon WF, Basking LS, Jonas U, Tanagho EA, Schmidt RA (1991) Neuromodulation of voiding dysfunction and pelvic pain. World J Urol 9:138–141
Janknegt RA, Weil EH, Eerdmans PH (1997) Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 49:358–362
Spinelli M, Giardiello G, Gerber M (2003) New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 170:1905–1907
Borawsky KM, Foster RT, Webster GD, Amundsen CL (2007) Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinence women. Neurourol Urodyn 26:14–18
van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama á Nijholt AA, Siegel S, Jonas U, Fowler CJ, Fall M, Gajewski JB, Hassouna MM, Cappellano F, Elhilali MM, Milam DF, Das AK, Dijkema HE, van den Hombergh U (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178:2029–2034
White WM, Dobmeyer-Dittrich C, Klein FA, Wallace LS (2008) Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability. Urology 71:71–74
De Ridder D, Ost D, Bruyninckx F (2007) The presence of Fowler’s syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention. Eur Urol 51:229–233
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bertapelle, M.P. (2015). Sacral Nerve Modulation for Urinary Disorders: Urinary Retention. In: Martellucci, J. (eds) Electrical Stimulation for Pelvic Floor Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-06947-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-06947-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06946-3
Online ISBN: 978-3-319-06947-0
eBook Packages: MedicineMedicine (R0)